250
Participants
Start Date
August 11, 2025
Primary Completion Date
November 4, 2027
Study Completion Date
November 4, 2027
MK-5684
Tablet for oral administration.
Fludrocortisone/ Fludrocortisone acetate
Tablet for oral administration.
Dexamethasone/Dexamethasone acetate
Tablet for oral administration.
Rescue Medications
Hydrocortisone or hydrocortisone/hydrocortisone acetate administered via intramuscular injection as rescue medication.
Fulvestrant
Administered via intramuscular injection.
Exemestane
Tablet for oral administration.
Megestrol acetate/Medroxyprogesterone acetate
Tablet for oral administration.
Tamoxifen
Tablet for oral administration.
Letrozole
Tablet for oral administration.
RECRUITING
National Cheng Kung University Hospital ( Site 1003), Tainan City
RECRUITING
Mackay Memorial Hospital ( Site 1002), Taipei
RECRUITING
CHUAC-Complejo Hospitalario Universitario A Coruña ( Site 2003), A Coruña
RECRUITING
Clinica Universitaria Navarra - Madrid ( Site 2004), Madrid
RECRUITING
Hospital Universitario Ramón y Cajal-Medical Oncology ( Site 2002), Madrid
RECRUITING
HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID-ONCOLOGIA MEDICA ( Site 2001), Madrid
RECRUITING
Mount Sinai Cancer Center ( Site 0009), Miami Beach
RECRUITING
Mary Lanning Healthcare ( Site 0019), Hastings
RECRUITING
TRIALS 365 ( Site 0022), Shreveport
RECRUITING
Institut Català d'Oncologia - L'Hospitalet-Medical Oncology ( Site 2000), L'Hospitalet de Llobregat
RECRUITING
The Christie NHS Foundation Trust ( Site 2300), Manchester
Merck Sharp & Dohme LLC
INDUSTRY